PCR214 The Value of Technology to Reduce Barriers to Clinical Trial Diversity and Facilitate the Development of Patient-Centric Medicine

Abstract

Historically, participants of clinical trials have not been representative of the target patient pool, with women, ethnic minorities, and the elderly being consistently under-represented. This lack of diversity in clinical research can have significant impacts on understanding the effectiveness and safety of a treatment, with more frequent adverse effects occurring in under-represented groups. Barriers to patient participation include medical mistrust, eligibility requirements, and lack of access. This research aims to explore how advances in technology can increase patient centricity in trials, reduce burden of trial participation, and increase access to a broader and more diverse pool of patients.